241 Users Online
Global Enteral Feeding Formula Market by Product Type (Standard Formula, Disease-specific Formula)
Newly released Enteral Feeding Formula Market analysis report by Persistence Market Research shows that global sales of Enteral Feeding Formula Market in 2022 was held at US$ 6.4 Bn. With a CAGR of 7.1% during 2023 - 2033, the market is projected to reach a valuation of US$ 13.5 Bn by 2033. Standard Formula is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 7.8% during 2023 – 2033.
Global Enteral Feeding Formula Market (2023)
US$ 6.8 Bn
Global Enteral Feeding Formula Market (2033)
US$ 13.5 Bn
Global Enteral Feeding Formula Market CAGR (2023 – 2033)
U.S. Enteral Feeding Formula Market CAGR (2023 – 2033)
Key Companies Profiled
As per the Enteral Feeding Formula Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Enteral Feeding Formula Market increased at around 6.7% CAGR.
Enteral nutrition, commonly known as tube feeding, refers to any feeding strategy through the gastrointestinal system to supply caloric needs, such as a regular oral meal or liquid supplements. A nasoenteral tube is inserted through the nose into the stomach, while a jejunostomy tube is inserted through the skin.
Tube feeding formula is utilized in individuals with chronic diseases such as head trauma, cancer, and stroke. Furthermore, the nutrition formula assists preterm newborns in obtaining the necessary nutrients and drugs. Enteral nutrition is indicated for patients with chronic illness conditions to counteract a weakened immune system, which affects eating patterns and results in significant weight loss.
Patients who have difficulty swallowing meals are given external nourishment through a tube. As a result, the rise in chronic illnesses such as cancer and cardiovascular disease is likely to fuel market development throughout the forecast period. Moreover, the increased prevalence of malnutrition is propelling the global enteral nutrition market forward. At the same time, increasing government efforts, investments, and funding for R&D are likely to fuel market expansion throughout the projection period.
Furthermore, factors such as investments in research and development of innovative medical nutritional products targeting various health issues, as well as financing from various nutrition industry businesses, are likely to fuel the worldwide enteral nutrition market growth throughout the forecast period.
With expanding therapeutic uses of enteral feeding formula and the launch of new technologically enhanced enteral feeding formula, demand for enteral feeding formula is booming. Furthermore, the expanding elderly population worldwide, as well as the rising occurrence of preterm births, are driving market expansion.
The need for enteral feeding formulae grows in tandem with the number of COVID-19 patients admitted to hospitals. The critical care segment of the enteral feeding formula business is rapidly increasing due to a growth in the number of COVID-19 patients, which is also pushing the consumption of nutritious feeding Formula among ventilator-dependent patients.
Increased awareness among healthcare workers about hospital-associated malnutrition is expected to increase the use of enteral feeding Formula in hospitals. Furthermore, the increased number of ICU admissions during COVID-19, as well as the rising need for enteral formulations among critically ill patients, are expected to drive market growth.
An aging population and a rising demand for home care primarily drive the market. The development of inexpensive and effective diabetes medication, as well as people's knowledge of diabetes self-management and government assistance, are all driving market expansion. Factors such as an increase in preterm deliveries and an increase in the frequency of malnutrition in hospitalized children are driving up demand for these formulas.
The primary constraints impeding the growth of the enteral nutrition market are the adverse effects and problems associated with enteral feedings. Aggressive enteral feeding may increase the risk of aspiration or vomiting in a kid with gastroesophageal reflux. Other physical drawbacks include diarrhea, skin breakdown, and anatomic disturbance. A dislodged or clogged feeding tube is one of the mechanical drawbacks. Furthermore, in low- and medium-income nations, a lack of understanding about healthcare, diet, and correct nutrition is a key impediment to the growth of the worldwide enteral nutrition market.
Which Region is projected to Offer the Largest Opportunity for Enteral Feeding Formula Market?
In 2022, North America held the largest share of the global Enteral Feeding Formula market. Due to the reasons such as the expanding elderly population, the rising frequency of preterm birth, and the increasing number of chronic illness patients, North America dominates the worldwide enteral feeding formula market. Furthermore, since patients prefer home-based enteral treatment, the frequency of hospital and clinic visits has dropped. Also, rising malnutrition is predicted to drive up in the region which has been driving the market expansion.
U.S. Enteral Feeding Formula Market Analysis
The United States is expected to have the highest market share of US$ 3.5 Bn by the end of 2033. The market has previously grown at a considerable CAGR of 7.2% during the forecast period.
The expanding elderly population will increase the prevalence of chronic illnesses such as cancer and diabetes, resulting in a rise in patient hospitalization. Furthermore, according to the WHO, around 15 million kids are delivered prematurely, and this figure is growing. As a result, the market in the country is likely to expand throughout the forecast period.
U.K. Enteral Feeding Formula Market Analysis
The market in the U.K. is expected to reach a valuation of US$ 613 Mn by 2033, growing at a CAGR of 8.3% during 2023 – 2033. The market is projected to gross an absolute dollar opportunity of US$ 336 Mn during the forecast period.
Japan Enteral Feeding Formula Market Analysis
In Japan, the market is expected to reach a valuation of US$ 575 Mn by 2033. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 315 Mn, growing at a CAGR of 8.3%.
South Korea Enteral Feeding Formula Market Analysis
The market in South Korea is projected to grow at a CAGR of 6.9% during 2023 – 2033. During this period, the market is projected to witness an absolute dollar opportunity of US$ 143 Mn and reach US$ 292 Mn by 2033.
Which Product Type is expected to propel the growth for Enteral Feeding Formula providers?
Standard Formula commanded the largest revenue in the enteral feeding formula market and grew at a CAGR of 7.2% during 2018-22. The market through standard formula accounted for the largest market share due to the substantial demand for enteral nutrition and basic clinical nutrition, as well as increased investment by large corporations. Polymeric formulas and monomeric formulations are subsets of standard formulae. There are various modifications of standard Formula available due to the rising need for low-cost nutritional formulations. Volume-sensitive individuals and those with congestive heart failure are particularly fond of standard tube feeds.
Which Flow Type is expected to propel maximum growth for Enteral Feeding Formula providers?
Intermittent Feeding Flow commanded the largest revenue in this regard, growing at a CAGR of nearly 6.8% during 2018-22. Because intermittent feeding has been shown to be more tolerable in patients than bolus feeding, this segment accounted for the majority of market revenue. Furthermore, because this type of feeding does not need the use of feeding pumps, it allows for more mobility in between feedings. This is projected to increase its use in both hospital and homecare settings, boosting industry development.
Some of the key players operating in the enteral feeding formula market include Danone, Nestle Nutrition, Abbott Nutrition, Mead Johnson & Company, Fresenius Kabi AG, B. Braun Melsungen AG, Otsuka Holdings Co. Ltd., Nutritional Medicinals, LLC, Kate Farms, Medtrition Inc., Victus, Inc., Global Health Products, Inc., and Meiji Holdings.
Some of the recent developments of key Enteral Feeding Formula providers are as follows:
Similarly, recent developments related to companies in the Enteral Feeding Formula market have been tracked by the team at Persistence Market Research, which are available in the full report.
By Product Type
By Flow Type
The market is worth more than US$ 6.4 Bn at present.
The market value is projected to increase at a CAGR of around 6.7% during 2023 – 2033.
The market value increased at a CAGR of around 7.1% during 2018 – 2022.
The rising frequency of chronic illnesses, an increase in preterm births, and an aging population are the key factors driving growth in the industry.
The Enteral Feeding Formula Market in China is projected to expand at a CAGR of around 7.7% during 2023 – 2033.
While the market in South Korea is expected to grow at nearly 6.9%, the market in Japan is projected to register a CAGR of nearly 8.3% during 2023 - 2033.